White label – Pompe disease - ClinicalTrials.eu

Study on Amoxicillin and Clavulanic Acid to Prevent Infection in Women with Obstetric Perineal Tear

Not recruiting

3 1 1
Investigated Diseases:
- Perineal injury
Investigated Drugs:
- Clavulanic Acid
- Amoxicillin
Study of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Telisotuzumab Vedotin
Study of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy

Not recruiting

2 1 1
Investigated Diseases:
- Partial seizures
Investigated Drugs:
- Ivermectin
+2
Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Hhalpc
Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

Not recruiting

2 1 1
Investigated Diseases:
- Follicular lymphoma
Investigated Drugs:
- Mosunetuzumab
Study on Botulinum Toxin Type A for Reducing Jaw Muscle Size in Adults with Prominent Masseter Muscle

Not recruiting

3 1 1
Investigated Drugs:
- Botulinum Toxin Type A
+1
Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
Study on the Safety and Effects of Ixodes ricinus Contact Phase Inhibitor in Adults with Spontaneous Brain Bleeding

Not recruiting

2 1 1
Investigated Drugs:
- Ixodes Ricinus Contact Phase Inhibitor
Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

Not recruiting

3 1 1 1
Investigated Drugs:
- Adalimumab
- Upadacitinib
+11
Study of Pembrolizumab for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:
- Pembrolizumab
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies